Rite Aid Reports Same Store Sales for September

Go back to Rite Aid Reports Same Store Sales for September

Rite-Aid's (RAD) Buy Rating Maintained at Deutsche Bank

October 1, 2015 3:33 PM EDT

Deutsche Bank maintained a Buy rating on Rite-Aid (NYSE: RAD) with a price target of $9. Earlier Rite-Aid reported September comps increased 1.5%. In the view of analyst George Hill, soft script trends were not a surprise.

"Prescription count at comparable stores for the month decreased -0.7%. Pharmacy same store sales for September grew +2.2%, incorporating a -234 bps impact from new generic drug introductions.... More

Rite Aid (RAD) Sept. Sames Store Sales Increase 1.5%

October 1, 2015 8:32 AM EDT

Rite Aid Corporation (NYSE: RAD) today announced sales results of its retail pharmacy segment for September.

Monthly Sales

For the four weeks ended Sept. 26, 2015, same store sales increased 1.5 percent over the prior-year period. September front-end same store sales decreased 0.1 percent. Pharmacy same store sales,... More